FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989771971> ?p ?o ?g. }

• W2989771971 endingPage "e0225225" @default.
• W2989771971 startingPage "e0225225" @default.
• W2989771971 abstract "The introduction of imatinib, an oral tyrosine kinase inhibitor, as first-line standard therapy in patients with unresectable, metastatic, or recurrent gastro-intestinal stromal tumor (GIST), strongly improved their treatment outcomes. However, therapeutic drug monitoring (TDM) is recommended for this drug due to the large inter-individual variability in plasma concentration when standard dose is administered. A Cmin higher than 760 ng/mL was associated with a longer progression free survival. Thus, a LC-MS/MS method has been developed and fully validated to quantify imatinib and its active metabolite, norimatinib, in finger-prick dried blood spot (DBS). The influence of hematocrit, sample homogeneity, and spot size and the correlation between finger-prick and venous DBS measurements were also assessed. The method showed a good linearity (R2 > 0,996) between 50-7500 ng/mL for imatinib and 10-1500 ng/mL for norimatinib. Analytes were extracted from DBS samples by simply adding to 3 mm-discs 150 μL of acidified methanol containing IMA-D8. The collected extract was then injected on a LC Nexera system in-house configured for the on-line cleanup, coupled with an API-4000 QT. The chromatographic separation was conducted on a Synergi Fusion-RP column (4 μm, 2x50 mm) while the trapping column was a POROS R1/20 (20 μm, 2x30 mm). The total run time was 8.5 min. DBSs stored at room temperature in plastic envelopes containing a silica-gel drying bag were stable up to 16 months. The proposed method was applied to 67 clinical samples, showing a good correlation between patients' finger-prick DBS and plasma concentrations, measured by the reference LC-MS/MS method, internally validated. Imatinib and norimatinib concentrations found in finger-prick DBS were adjusted by hematocrit or by an experimental correction factor to estimate the corresponding plasma measurements. At the best of our knowledge, the proposed LC-MS/MS method is the first analytical assay to measure imatinib and norimatinib in DBS samples." @default.
• W2989771971 created "2019-12-05" @default.
• W2989771971 creator A5003339272 @default.
• W2989771971 creator A5008025189 @default.
• W2989771971 creator A5011786716 @default.
• W2989771971 creator A5015716804 @default.
• W2989771971 creator A5019276549 @default.
• W2989771971 creator A5045314994 @default.
• W2989771971 creator A5052572219 @default.
• W2989771971 creator A5058657353 @default.
• W2989771971 creator A5059150956 @default.
• W2989771971 creator A5068048791 @default.
• W2989771971 creator A5072799744 @default.
• W2989771971 creator A5079263249 @default.
• W2989771971 date "2019-11-19" @default.
• W2989771971 modified "2023-09-29" @default.
• W2989771971 title "Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients" @default.
• W2989771971 cites W1531330393 @default.
• W2989771971 cites W1971113538 @default.
• W2989771971 cites W1995930366 @default.
• W2989771971 cites W2023187096 @default.
• W2989771971 cites W2028959752 @default.
• W2989771971 cites W2042516926 @default.
• W2989771971 cites W2047727316 @default.
• W2989771971 cites W2048114154 @default.
• W2989771971 cites W2050646947 @default.
• W2989771971 cites W2057627287 @default.
• W2989771971 cites W2063669413 @default.
• W2989771971 cites W2070719980 @default.
• W2989771971 cites W2071774846 @default.
• W2989771971 cites W2119227173 @default.
• W2989771971 cites W2123346471 @default.
• W2989771971 cites W2133365230 @default.
• W2989771971 cites W2149330162 @default.
• W2989771971 cites W2150468109 @default.
• W2989771971 cites W2152036882 @default.
• W2989771971 cites W2157830465 @default.
• W2989771971 cites W2372510539 @default.
• W2989771971 cites W2613332809 @default.
• W2989771971 doi "https://doi.org/10.1371/journal.pone.0225225" @default.
• W2989771971 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6863526" @default.
• W2989771971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31743371" @default.
• W2989771971 hasPublicationYear "2019" @default.
• W2989771971 type Work @default.
• W2989771971 sameAs 2989771971 @default.
• W2989771971 citedByCount "19" @default.
• W2989771971 countsByYear W29897719712020 @default.
• W2989771971 countsByYear W29897719712021 @default.
• W2989771971 countsByYear W29897719712022 @default.
• W2989771971 countsByYear W29897719712023 @default.
• W2989771971 crossrefType "journal-article" @default.
• W2989771971 hasAuthorship W2989771971A5003339272 @default.
• W2989771971 hasAuthorship W2989771971A5008025189 @default.
• W2989771971 hasAuthorship W2989771971A5011786716 @default.
• W2989771971 hasAuthorship W2989771971A5015716804 @default.
• W2989771971 hasAuthorship W2989771971A5019276549 @default.
• W2989771971 hasAuthorship W2989771971A5045314994 @default.
• W2989771971 hasAuthorship W2989771971A5052572219 @default.
• W2989771971 hasAuthorship W2989771971A5058657353 @default.
• W2989771971 hasAuthorship W2989771971A5059150956 @default.
• W2989771971 hasAuthorship W2989771971A5068048791 @default.
• W2989771971 hasAuthorship W2989771971A5072799744 @default.
• W2989771971 hasAuthorship W2989771971A5079263249 @default.
• W2989771971 hasBestOaLocation W29897719711 @default.
• W2989771971 hasConcept C112705442 @default.
• W2989771971 hasConcept C126322002 @default.
• W2989771971 hasConcept C149151106 @default.
• W2989771971 hasConcept C16930146 @default.
• W2989771971 hasConcept C185592680 @default.
• W2989771971 hasConcept C22979827 @default.
• W2989771971 hasConcept C2775922572 @default.
• W2989771971 hasConcept C2776597655 @default.
• W2989771971 hasConcept C2777583451 @default.
• W2989771971 hasConcept C2778335254 @default.
• W2989771971 hasConcept C2778729363 @default.
• W2989771971 hasConcept C2780272996 @default.
• W2989771971 hasConcept C3019892230 @default.
• W2989771971 hasConcept C43617362 @default.
• W2989771971 hasConcept C71924100 @default.
• W2989771971 hasConcept C98274493 @default.
• W2989771971 hasConceptScore W2989771971C112705442 @default.
• W2989771971 hasConceptScore W2989771971C126322002 @default.
• W2989771971 hasConceptScore W2989771971C149151106 @default.
• W2989771971 hasConceptScore W2989771971C16930146 @default.
• W2989771971 hasConceptScore W2989771971C185592680 @default.
• W2989771971 hasConceptScore W2989771971C22979827 @default.
• W2989771971 hasConceptScore W2989771971C2775922572 @default.
• W2989771971 hasConceptScore W2989771971C2776597655 @default.
• W2989771971 hasConceptScore W2989771971C2777583451 @default.
• W2989771971 hasConceptScore W2989771971C2778335254 @default.
• W2989771971 hasConceptScore W2989771971C2778729363 @default.
• W2989771971 hasConceptScore W2989771971C2780272996 @default.
• W2989771971 hasConceptScore W2989771971C3019892230 @default.
• W2989771971 hasConceptScore W2989771971C43617362 @default.
• W2989771971 hasConceptScore W2989771971C71924100 @default.
• W2989771971 hasConceptScore W2989771971C98274493 @default.
• W2989771971 hasIssue "11" @default.
• W2989771971 hasLocation W29897719711 @default.

• next